Your browser doesn't support javascript.
loading
Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells
Biomolecules & Therapeutics ; : 258-263, 2013.
Article in English | WPRIM | ID: wpr-59935
ABSTRACT
We demonstrate herein that silibinin, a polyphenolic flavonoid compound isolated from milk thistle (Silybum marianum), inhibits LPS-induced activation of macrophages and production of nitric oxide (NO) in RAW 264.7 cells. Western blot analysis showed silibinin inhibits iNOS gene expression. RT-PCR showed that silibinin inhibits iNOS, TNF-alpha, and IL1beta. We also showed that silibinin strongly inhibits p38 MAPK phosphorylation, whereas the ERK1/2 and JNK pathways are not inhibited. The p38 MAPK inhibitor abrogated the LPS-induced nitrite production, whereas the MEK-1 inhibitor did not affect the nitrite production. A molecular modeling study proposed a binding pose for silibinin targeting the ATP binding site of p38 MAPK (1OUK). Collectively, this series of experiments indicates that silibinin inhibits macrophage activation by blocking p38 MAPK signaling.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Phosphorylation / Binding Sites / Models, Molecular / Gene Expression / Adenosine Triphosphate / Blotting, Western / Tumor Necrosis Factor-alpha / Milk Thistle / MAP Kinase Signaling System / P38 Mitogen-Activated Protein Kinases Type of study: Prognostic study Language: English Journal: Biomolecules & Therapeutics Year: 2013 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Phosphorylation / Binding Sites / Models, Molecular / Gene Expression / Adenosine Triphosphate / Blotting, Western / Tumor Necrosis Factor-alpha / Milk Thistle / MAP Kinase Signaling System / P38 Mitogen-Activated Protein Kinases Type of study: Prognostic study Language: English Journal: Biomolecules & Therapeutics Year: 2013 Type: Article